A discovery that has already saved millions of lives. The work isn’t over yet – there are 70 million people currently living with the virus, which still kills around 400,000 a year.
In Cameroon, around 200,000 people are chronically ill with HCV. Prof. dr. Roel Coutinho, member of the PharmAccess medical team, works together with a local team of doctors and researchers on making HCV treatment accessible in Cameroon. With their pivotal research they proved successful HCV treatment in Cameroon is possible, and developed a performance-based financing model together with Joep Lange Institute and Achmea Foundation.
PharmAccess is excited to see more recognition for Hepatitis C with this Nobel Prize.
For more information on the research of Prof. dr. Roel Coutinho and the local Cameroonian team, read our article on Medium, or listen to this radio interview (in Dutch) with Prof. dr. Roel Coutinho on NPO radio 1.